Anthony Hickey

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter

Filter by Type

Search Results

Dry Powder PA-824 Aerosols for Treatment of Tuberculosis in Guinea Pigs

Particle Interactions in Dry Powder Inhaler Unit Processes: A Review

Rational Design of Multiple TB Antigens TB10.4 and TB10.4-Ag85B as Subunit Vaccine Candidates Against Mycobacterium Tuberculosis

Inhaled drug therapy for treatment of tuberculosis

Isoxyl Aerosols for Tuberculosis Treatment: Preparation and Characterization of Particles

Pulmonary Immunization of Guinea Pigs with Diphtheria CRM-197 Antigen as Nanoparticle Aggregate Dry Powders Enhance Local and Systemic Immune Responses

Optimisation of inhaled tuberculosis therapies and implications for host-pathogen interactions

Isoxyl particles for pulmonary delivery: In vitro cytotoxicity and potency

Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1

Dry Powder Aerosols Generated by Standardized Entrainment Tubes From Drug Blends With Lactose Monohydrate: 2. Ipratropium Bromide Monohydrate and Fluticasone Propionate

Dry Powder Aerosols Generated by Standardized Entrainment Tubes from Alternative Sugar Blends: 3. Trehalose Dihydrate and D-Mannitol Carriers

Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop Summary Report

PLGA Microparticles in Respirable Sizes Enhance an In Vitro T Cell Response to Recombinant Mycobacterium Tuberculosis Antigen TB10.4-Ag85B

Immunization of Guinea Pigs with Novel Hepatitis B Antigen as Nanoparticle Aggregate Powders Administered by the Pulmonary Route

Nebulizer delivery of micafungin aerosols

Dry Powder Aerosols Generated by Standardized Entrainment Tubes From Drug Blends With Lactose Monohydrate: 1. Albuterol Sulfate and Disodium Cromoglycate

Estimation of Particle Deposition in the Airways From Different Inhaler Formulations Using an In Silico Model

Optimisation of inhaled tuberculosis therapies and implications for host–pathogen interactions

Heterogeneous Particle Deaggregation and Its Implication for Therapeutic Aerosol Performance

Pharmaco-Complexity: Non-Linear Phenomena and Drug Product Development